Pharmaceutical Executive December 7, 2021
Jill Wechsler, Pharm Exec’s Washington Correspondent

As Congress struggles to reach agreement on major legislation to fund leading administration social and spending initiatives and to raise the debt limit to avoid default on government borrowing, the White House is emphasizing that reduced spending on prescription drugs can help offset some of the steep costs. President Joe Biden highlighted how current proposals for curbing outlays on pharmaceuticals will help protect patients’ health and save the government billions in a speech December 6, 2021 on strategies for controlling drug costs.1

Even though Biden applauded the efforts by pharmaceutical companies in developing life-saving vaccines and treatments for fight COVID-19, he criticized industry for jacking up prices on medicines that have been on the market for years. This leaves Americans...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Pharma / Biotech, Pricing / Spending
Biden cracks down on junk health plans
White House issues federal agency policy on AI use, oversight
Administration finalizes rule limiting short-term, limited-duration insurance
White House Wants Chief AI Officers to Keep Federal AI Use Responsible
GOP plans for Medicaid cuts could face backlash

Share This Article